• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体系统与激肽系统在血管通透性中的相互作用。

Cross-talk between the complement and the kinin system in vascular permeability.

机构信息

Department of Life Sciences, University of Trieste, via Valerio 28, 34127 Trieste, Italy.

出版信息

Immunol Lett. 2011 Oct 30;140(1-2):7-13. doi: 10.1016/j.imlet.2011.06.006. Epub 2011 Jul 6.

DOI:10.1016/j.imlet.2011.06.006
PMID:21762728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3162365/
Abstract

The endothelium is a continuous physical barrier that regulates coagulation and selective passage of soluble molecules and circulating cells through the vessel wall into the tissue. Due to its anatomic localization, the endothelium may establish contact with components of the complement, the kinin and the coagulation systems which are the main, though not exclusive, inducers of vascular leakage. Although the complement and the kinin systems may act independently, increasing evidence suggest that there is a crosstalk that involve different components of both systems. Activation is required for the function of the two systems which are involved in pathological conditions such as hereditary and acquired angioedema (AE) and vasculitidis. The aim of this review is to discuss the contribution of complement and kinin systems to vascular leakage and the cross-talk between the two systems in the development of AE. This clinical condition is characterized by episodic and recurrent local edema of subcutaneous and submucosal tissues and is due to inherited or acquired C1-INH deficiency. Although the pathogenesis of the swelling in patients with AE was originally thought to be mediated by C2, ample evidence indicate bradykinin (BK) as the most effective mediator even though the possibility that both the complement and the kinin-forming systems may contribute to the edema has not been completely excluded. BK induces endothelial leakage interacting with B2 receptors but other molecules may be involved in the onset and maintenance of AE. In this review we shall discuss the role of B1 receptors and gC1qR/p33 in addition to that of B2 receptors in the onset of AE attacks and the importance of these receptors as new possible molecular targets for therapy.

摘要

内皮细胞是一种连续的物理屏障,可调节凝血和可溶性分子及循环细胞通过血管壁选择性地进入组织。由于其解剖位置,内皮细胞可能与补体、激肽和凝血系统的成分接触,这些成分是血管渗漏的主要(尽管不是唯一)诱导物。虽然补体和激肽系统可以独立作用,但越来越多的证据表明,这两个系统之间存在涉及不同成分的串扰。两种系统的激活是其发挥功能所必需的,它们参与遗传性和获得性血管性水肿(AE)和血管炎等病理状况。本综述的目的是讨论补体和激肽系统对血管渗漏的贡献,以及这两个系统在 AE 发病机制中的相互作用。这种临床病症的特征是皮下和黏膜下组织的局部间歇性和复发性水肿,是由于遗传或获得性 C1-INH 缺乏引起的。尽管最初认为 AE 患者的肿胀是由 C2 介导的,但大量证据表明缓激肽(BK)是最有效的介质,尽管补体和激肽形成系统都可能导致水肿的可能性尚未完全排除。BK 通过与 B2 受体相互作用诱导内皮细胞渗漏,但其他分子可能参与 AE 的发作和维持。在本综述中,我们将讨论 B1 受体和 gC1qR/p33 的作用,除了 B2 受体在 AE 发作中的作用,以及这些受体作为新的可能的治疗分子靶点的重要性。

相似文献

1
Cross-talk between the complement and the kinin system in vascular permeability.补体系统与激肽系统在血管通透性中的相互作用。
Immunol Lett. 2011 Oct 30;140(1-2):7-13. doi: 10.1016/j.imlet.2011.06.006. Epub 2011 Jul 6.
2
The Role of Complement in Hereditary Angioedema.补体在遗传性血管性水肿中的作用。
Transfus Med Rev. 2019 Oct;33(4):243-247. doi: 10.1016/j.tmrv.2019.08.002. Epub 2019 Aug 29.
3
Hereditary angioedema attack: what happens to vasoactive mediators?遗传性血管性水肿发作:血管活性介质发生了什么变化?
Int Immunopharmacol. 2020 Jan;78:106079. doi: 10.1016/j.intimp.2019.106079. Epub 2019 Dec 13.
4
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.与 C1 抑制剂缺乏相关的血管性水肿的新型发病机制和治疗方法。
J Allergy Clin Immunol. 2009 Dec;124(6):1303-10.e4. doi: 10.1016/j.jaci.2009.08.007.
5
Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.依卡替班,缓激肽 B2 受体拮抗剂,作用于相互关联的激肽系统。
Expert Opin Pharmacother. 2012 Oct;13(15):2233-47. doi: 10.1517/14656566.2012.723692. Epub 2012 Sep 13.
6
Update on therapeutic developments for hereditary angioedema.遗传性血管性水肿治疗进展
Allergy Asthma Proc. 2009 Sep-Oct;30(5):500-5. doi: 10.2500/aap.2009.30.3282.
7
The plasma bradykinin-forming pathways and its interrelationships with complement.血浆缓激肽形成途径及其与补体的相互关系。
Mol Immunol. 2010 Aug;47(13):2161-9. doi: 10.1016/j.molimm.2010.05.010.
8
Current pharmacotherapy of bradykinin-mediated angioedema.缓激肽介导的血管性水肿的当前药物治疗。
Expert Opin Pharmacother. 2013 Apr;14(5):571-86. doi: 10.1517/14656566.2013.778826.
9
Hereditary angioedema: the plasma contact system out of control.遗传性血管性水肿:失控的血浆接触系统。
J Thromb Haemost. 2018 Sep;16(9):1674-1685. doi: 10.1111/jth.14209. Epub 2018 Jul 17.
10
Role of the B1 bradykinin receptor and gC1qR/p33 in angioedema.B1 缓激肽受体和 gC1qR/p33 在血管性水肿中的作用。
Immunol Allergy Clin North Am. 2013 Nov;33(4):535-44. doi: 10.1016/j.iac.2013.07.008. Epub 2013 Sep 5.

引用本文的文献

1
Pathogenicity and virulence of Rodent-Borne Orthohantaviruses.啮齿动物传播的正汉坦病毒的致病性和毒力
Virulence. 2025 Dec;16(1):2553784. doi: 10.1080/21505594.2025.2553784. Epub 2025 Sep 4.
2
Impact of smoking on the complement system: a narrative review.吸烟对补体系统的影响:一项叙述性综述。
Front Immunol. 2025 Jun 19;16:1619835. doi: 10.3389/fimmu.2025.1619835. eCollection 2025.
3
Kinin B Receptor Agonist Enhances Blood-Brain Barrier Permeability in Healthy and Glioblastoma Environments.激肽B受体激动剂增强健康和胶质母细胞瘤环境中的血脑屏障通透性。

本文引用的文献

1
Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).通过表面等离子体共振(BiaCore)技术测定高分子量激肽原与内皮细胞结合蛋白 suPAR、gC1qR 和细胞角蛋白 1 的相互作用。
Thromb Haemost. 2011 Jun;105(6):1053-9. doi: 10.1160/TH10-09-0591. Epub 2011 May 5.
2
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.依卡替班,一种新型缓激肽受体拮抗剂,用于遗传性血管性水肿。
N Engl J Med. 2010 Aug 5;363(6):532-41. doi: 10.1056/NEJMoa0906393.
3
Complement: a key system for immune surveillance and homeostasis.
Pharmaceuticals (Basel). 2025 Apr 18;18(4):591. doi: 10.3390/ph18040591.
4
Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate.脓毒症期间接触、凝血和补体系统的病理生理动力学:甲磺酸萘莫司他的潜在靶点。
J Intensive Med. 2024 Apr 10;4(4):453-467. doi: 10.1016/j.jointm.2024.02.003. eCollection 2024 Oct.
5
Assessment of the effect of 21-day head-down bed rest on the cardiovascular system by blood protein composition.通过血液蛋白质成分评估21天头低位卧床休息对心血管系统的影响。
Front Physiol. 2024 Jun 20;15:1375929. doi: 10.3389/fphys.2024.1375929. eCollection 2024.
6
Kinin B receptor and TLR4 interaction in inflammatory response.缓激肽 B 受体与 TLR4 在炎症反应中的相互作用。
Inflamm Res. 2024 Sep;73(9):1459-1476. doi: 10.1007/s00011-024-01909-1. Epub 2024 Jul 4.
7
Circulating Blood Prognostic Biomarker Signatures for Hemorrhagic Cerebral Cavernous Malformations (CCMs).循环血液预后生物标志物特征与出血性海绵状脑血管瘤(CCMs)。
Int J Mol Sci. 2024 Apr 26;25(9):4740. doi: 10.3390/ijms25094740.
8
Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target.补体作为急性呼吸窘迫综合征病理生物学连接组的重要枢纽:一个新兴的治疗靶点。
Front Immunol. 2023 Mar 17;14:1100461. doi: 10.3389/fimmu.2023.1100461. eCollection 2023.
9
Indices of complement activation and coagulation changes in trauma patients.创伤患者补体激活和凝血变化指标。
Trauma Surg Acute Care Open. 2022 Sep 14;7(1):e000927. doi: 10.1136/tsaco-2022-000927. eCollection 2022.
10
Interactions amongst inflammation, renin-angiotensin-aldosterone and kallikrein-kinin systems: suggestive approaches for COVID-19 therapy.炎症、肾素-血管紧张素-醛固酮系统与激肽释放酶-激肽系统之间的相互作用:COVID-19治疗的潜在方法
J Venom Anim Toxins Incl Trop Dis. 2021 Dec 6;27:e20200181. doi: 10.1590/1678-9199-JVATITD-2020-0181. eCollection 2021.
补体:免疫监视和稳态的关键系统。
Nat Immunol. 2010 Sep;11(9):785-97. doi: 10.1038/ni.1923. Epub 2010 Aug 19.
4
Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.用 siRNA 沉默 C5a 受体基因以防止革兰氏阴性菌脂多糖诱导的血管通透性增加。
Mol Immunol. 2010 Mar;47(6):1325-33. doi: 10.1016/j.molimm.2009.11.001. Epub 2010 Feb 6.
5
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.与 C1 抑制剂缺乏相关的血管性水肿的新型发病机制和治疗方法。
J Allergy Clin Immunol. 2009 Dec;124(6):1303-10.e4. doi: 10.1016/j.jaci.2009.08.007.
6
Paths reunited: Initiation of the classical and lectin pathways of complement activation.途径重连:经典途径和补体激活的凝集素途径的启动。
Immunobiology. 2010;215(1):1-11. doi: 10.1016/j.imbio.2009.08.006. Epub 2009 Sep 27.
7
Biomechanical comparison of techniques to reduce the bulk of lacerated flexor tendon ends within digital sheaths of the porcine forelimb.猪前肢指腱鞘内减少撕裂屈肌腱末端体积的技术的生物力学比较。
J Hand Surg Am. 2009 Nov;34(9):1653-8. doi: 10.1016/j.jhsa.2009.06.028. Epub 2009 Sep 17.
8
Blockade of bradykinin B2 receptor more effectively reduces postischemic blood-brain barrier disruption and cytokines release than B1 receptor inhibition.与抑制缓激肽B1受体相比,阻断缓激肽B2受体能更有效地减轻缺血后血脑屏障的破坏及细胞因子的释放。
Biochem Biophys Res Commun. 2009 Oct 16;388(2):205-11. doi: 10.1016/j.bbrc.2009.07.135. Epub 2009 Aug 5.
9
C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function.C7在内皮细胞上表达,作为组装末端补体复合物的陷阱,可能发挥抗炎功能。
Blood. 2009 Apr 9;113(15):3640-8. doi: 10.1182/blood-2008-03-146472. Epub 2009 Jan 29.
10
Production of C5a by ASP, a serine protease released from Aeromonas sobria.温和气单胞菌释放的丝氨酸蛋白酶ASP产生C5a。
J Immunol. 2008 Sep 1;181(5):3602-8. doi: 10.4049/jimmunol.181.5.3602.